Analysis reveals antifungal susceptibility patterns in Candida species from vulvovaginal candidiasis, suggesting targeted treatment may reduce complications.
Key Points
C. albicans showed high susceptibility to all antifungals tested, with a notable 49 isolates identified in the study.
Among non-albicans Candida, C. tropicalis was prevalent, but C. glabrata and C. krusei displayed varying antifungal resistance characteristics.
Utilizing the broth microdilution method, the study adhered to CLSI guidelines, ensuring robust antifungal susceptibility testing of isolates.
The findings support the need for species-specific antifungal stewardship to enhance treatment efficacy and minimize recurrent vulvovaginal candidiasis.